Corsabe Capital
2
6M
2
0.06
2
- Stages of investment
- Areas of investment
Summary
In 1986 was created Corsabe Capital, which is appeared as VC. The company was established in Europe in Spain. The main office of represented VC is situated in the Barcelona.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2008. The higher amount of exits for fund were in 2015.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Corsabe Capital, startups are often financed by Najeti Capital, Grupo Intercom, Grupo Ferrer Internacional. The meaningful sponsors for the fund in investment in the same round are Laboratorios Ordesa. In the next rounds fund is usually obtained by Alzheimer's Drug Discovery Foundation.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. Among the most popular portfolio startups of the fund, we may highlight Oryzon Genomics. We can highlight the next thriving fund investment areas, such as Biotechnology, Human Resources.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.06
- Investments by industry
- Therapeutics (1)
- Genetics (1)
- Medical (1)
- Biotechnology (1)
- Employment (1) Show 2 more
- Investments by region
-
- Spain (2)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 0.50
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Oryzon Genomics | 12 Mar 2008 | Biotechnology, Genetics, Medical, Therapeutics | Early Stage Venture | 12M | Spain, Madrid, Community of Madrid |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.